Orasure Tech Inc (OSUR) 6.44 $OSUR Medical Instruments &

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 1:04 AM

Orasure Tech Inc (OSUR) 6.44 $OSUR

Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 175.64 (+2.47), ELGX: 14.24 (+0.54), WAT: 146.53 (+4.06), OSUR: 6.44 (+0.24)

Uptrend Call Working As OraSure Technologies Stock Rises 21.3% (OSUR)
Comtex SmarTrend(R) - Tue Jun 07, 1:29AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 10th, 2016 at $6.52. In approximately 4 months, OraSure Technologies has returned 21.26% as of today's recent price of $7.90.
OSUR: 6.44 (+0.24)

OraSure Technologies to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Tue May 31, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2016 Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet.
OSUR: 6.44 (+0.24)

Looking for a Growth Stock? Why It is Time to Focus on OraSure Technologies (OSUR)
Zacks Equity Research - Zacks Investment Research - Tue May 24, 8:48AM CDT
OraSure Technologies (OSUR) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Growth perspective.
OSUR: 6.44 (+0.24)

Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:18AM CDT
On May 11, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX). The stock currently carries a Zacks Rank #2 (Buy).
BSX: 23.90 (+0.24), LMAT: 13.70 (+0.14), NUVA: 60.82 (+1.11), OSUR: 6.44 (+0.24)

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
GlobeNewswire - Tue May 10, 5:44AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2016 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 17, 2016.
OSUR: 6.44 (+0.24)

OraSure Announces 2016 First Quarter Financial Results
GlobeNewswire - Wed May 04, 3:00PM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the first quarter ended March 31, 2016.
OSUR: 6.44 (+0.24)

OraSure Technologies to Present at the UBS 2016 Global Healthcare Conference
GlobeNewswire - Tue May 03, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS 2016 Global Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet.
OSUR: 6.44 (+0.24)

OraSure Technologies Appoints New Chief Science Officer
GlobeNewswire - Fri Apr 15, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that Michael Reed, Ph.D. has been named as the Company's Senior Vice President of Research and Development and Chief Science Officer. He will begin working at the Company on April 18, 2016.
OSUR: 6.44 (+0.24)

OraSure Technologies Earnings Conference Call Invitation
GlobeNewswire - Wed Apr 13, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 first quarter financial results, 2016 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2016.
OSUR: 6.44 (+0.24)

CVS Health Strong on Omnicare Buyout, Integration Prospects
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 1:40PM CDT
On Apr 12, 2016, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).
BAX: 46.65 (+0.53), RMD: 64.51 (+1.16), CVS: 96.74 (+1.24), OSUR: 6.44 (+0.24)

C.R. Bard at 52-Week High, Product Suite Holds the Key
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 11:40AM CDT
Shares of C.R. Bard Inc (BCR) rallied to a new 52-week high of $205.52 on Apr 1, eventually closing a tad bit lower at $204.69.
BCR: 239.00 (+1.20), ALGN: 82.93 (+1.04), BAX: 46.65 (+0.53), OSUR: 6.44 (+0.24)

Thermo Fisher Steals Affymetrix Deal, Expands Antibody Line
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 10:10AM CDT
With the closure of the Affymetrix deal, Thermo Fisher(TMO) expects to enjoy an extended antibody portfolio, which will boost the company's leadership in biosciences.
TMO: 152.69 (+3.63), BAX: 46.65 (+0.53), OFIX: 46.70 (+1.09), OSUR: 6.44 (+0.24)

Medtronic Unveils NURO System in US for Overactive Bladder
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:30PM CDT
We believe this product launch will allow Medtronic (MDT) to overcome the issues it has been facing in its Neuromodulation business division over the past couple of quarters
MDT: 88.36 (+0.87), OFIX: 46.70 (+1.09), HRC: 51.37 (+0.57), OSUR: 6.44 (+0.24)

Mead Johnson Launches Enfinitas Product Line in China
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:25PM CDT
Mead Johnson Nutrition Company (MJN) recently launched its Enfinitas premium-priced product line in China.
MJN: 89.36 (+1.43), BAX: 46.65 (+0.53), HRC: 51.37 (+0.57), OSUR: 6.44 (+0.24)

Quest Diagnostics Grows Through Organic, Inorganic Means
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:05PM CDT
On Mar 30, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
BAX: 46.65 (+0.53), DGX: 82.23 (+1.00), HRC: 51.37 (+0.57), OSUR: 6.44 (+0.24)

Cepheid Up on International Launch of Next-Gen MRSA Test
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 2:50PM CDT
Cepheid's (CPHD) Xpert MRSA NxG assay is a next-generation version of the market-leading molecular diagnostic test for Methicillin-Resistant Staphyloccus aureus (MRSA).
CPHD: 33.40 (+2.03), OFIX: 46.70 (+1.09), HRC: 51.37 (+0.57), OSUR: 6.44 (+0.24)

Stryker (SYK) Scales a 52-Week High: Right Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 11:40AM CDT
Shares of Stryker Corp (SYK) rallied to a new 52-week high of $106.92 on Mar 29, eventually closing a tad bit lower at $106.87.
BAX: 46.65 (+0.53), HRC: 51.37 (+0.57), OSUR: 6.44 (+0.24), SYK: 122.29 (+1.26)

Cardiovascular Systems: Market Dynamics, Margins Strong
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:45PM CDT
Currently, Cardiovascular Systems (CSII) stands to gain from several favorable trends existing in the PAD as well CAD market spaces
CSII: 19.62 (+1.12), OFIX: 46.70 (+1.09), HRC: 51.37 (+0.57), OSUR: 6.44 (+0.24)

Thermo Fisher to Acquire Affymetrix, Origin's Bid Falls Flat
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:40PM CDT
On completion, the Thermo Fisher(TMO)-Affymetrix (AFFX) deal is expected to generate attractive financial returns
TMO: 152.69 (+3.63), AFFX: 14.01 (+0.02), HRC: 51.37 (+0.57), OSUR: 6.44 (+0.24)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Class Action: Critical Investor Alert

An Investor's Wake-Up Call: Beta Bionics Lawsuit Folks, if you've got skin in the game with Beta Bionics (NASDAQ: BBNX), there's a storm on the horizon. We're talking big legal guns out and aimed at Beta Bionics with that class action suit looming. If you sunk some serious dough between July 30, 2025, and February 24, 2026, it's time to shake up and assess your losses....

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Northern Virginia's Housing Inventory Surges Despite Market Pressures

Unexpected Surge in Northern Virginia's Inventory Walking around Fairfax these days, you might feel like you're in a time warp, especially if you're tracking the housing market. See, while the rest of the country's housing market groans under sluggish sales and creeping prices, Northern Virginia's doing a dance of its own. Inventory's ballooning faster than a parade...

Enigmata Innovates AI Security with Finovifi Tie-Up

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Swanson Nexus Pro Launch: Boost for Dietitians

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Finding Your Ideal Home Cleaning Schedule: Insights

Tackling the Mess: What's Your Cleaning Game Plan? We each have our tidiness tales, but when it comes down to keeping the household shipshape, the professional cleaning schedule you pick can make all the difference. A fresh-off-the-press breakdown from HelloNation and their expert David Merreot can guide you through the choices, cutting through the clutter of confusion....

Concrete Admixtures Market: A Billion-Dollar Boom

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

VoxNexus Debuts On-Device AI: A Game-Changer for Languages

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

Beyond The Bounce Expands with Pro Pickleball Star

Pickleball's Power Play: The Media Move Out of the blue, the world of niche sports finds its hub. Beyond The Bounce steps up to the plate by roping in pickleball’s own Zane Navratil. The hype’s not in the spin here—this is serious business. The company plans to push the boundaries of the sport into mainstream media, or at least give it a decent shot. Zane Navratil:...